# FDA 483 - Robyn Sanders, MD - December 17, 2018

Source: https://www.globalkeysolutions.net/records/483/robyn-sanders-md/6f5ff2b3-d976-49ba-b820-3b1b7c2191a3

> FDA 483 for Robyn Sanders, MD on December 17, 2018. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Robyn Sanders, MD
- Inspection Date: 2018-12-17
- Product Type: drugs
- Office Name: Atlanta District Office
- Summary: An FDA inspection of Robyn Sanders, MD, a clinical investigator in Greensboro, NC, revealed significant deficiencies in the conduct of a clinical study. Observations included failures to obtain proper informed consent from human subjects and a lack of adherence to the investigational plan and the signed statement of investigator. These issues indicate serious non-compliance with regulations governing clinical trials.

## Related Officers

- [William P Tonkins](https://www.globalkeysolutions.net/people/william-p-tonkins/81f1cec1-2376-4967-9656-513a9a64dac0)

Company: https://www.globalkeysolutions.net/companies/robyn-sanders-md/c8c16aa2-ba55-4104-ab35-0ef6ece5474c

Office: https://www.globalkeysolutions.net/offices/atlanta-district-office/7586d99a-288e-49d1-8c3d-d88b7354b7a7